Who
John Militello
Officer
Company insider
Files Form 4 as: Officer, Rocket Pharmaceuticals; Officer, Immune Pharmaceuticals.
In numbers
- Trades disclosed
- 129
- Buys
- 0
- Sells
- 31
- Bought
- $0
- Sold
- $948K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 31 Dec 2015
- Last trade
- 26 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —28,910 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —49,798 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —24,545 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,509 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,002 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,061 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,899 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,091 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,000 | filing |
| 26 May 2026filed 28 May 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —27,003 | filing |
News
Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facilityRCKT · proactiveinvestors.com · 7 Oct 2026
0 headlines in the last 90 days name John Militello; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.